UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Holdings in Bath & Body Works, Inc. $BBWI

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 9.2% in the second quarter, Holdings Channel reports. The firm owned 595,549 shares of the company’s stock after acquiring an additional 50,051 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Bath & Body Works were worth $13,775,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Parallel Advisors LLC increased its position in shares of Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after acquiring an additional 567 shares during the period. State of Michigan Retirement System increased its holdings in Bath & Body Works by 1.2% during the 1st quarter. State of Michigan Retirement System now owns 49,300 shares of the company’s stock worth $920,000 after purchasing an additional 600 shares during the period. Meeder Asset Management Inc. raised its position in Bath & Body Works by 28.5% during the 4th quarter. Meeder Asset Management Inc. now owns 2,874 shares of the company’s stock valued at $58,000 after purchasing an additional 637 shares in the last quarter. State of Wyoming lifted its holdings in shares of Bath & Body Works by 6.2% in the 2nd quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after buying an additional 661 shares during the period. Finally, Vident Advisory LLC lifted its holdings in shares of Bath & Body Works by 2.8% in the 2nd quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock worth $756,000 after buying an additional 692 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

BBWI stock opened at $19.56 on Friday. Bath & Body Works, Inc. has a one year low of $14.27 and a one year high of $32.03. The firm has a market cap of $3.94 billion, a price-to-earnings ratio of 5.09, a PEG ratio of 2.01 and a beta of 1.38. The firm has a 50-day simple moving average of $20.06 and a two-hundred day simple moving average of $19.83.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.24 by $0.38. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The firm had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.50 billion. During the same quarter in the previous year, the business posted $0.30 EPS. Bath & Body Works’s revenue was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, equities analysts predict that Bath & Body Works, Inc. will post 2.73 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 4th. Stockholders of record on Friday, August 21st were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 4.1%. The ex-dividend date was Friday, August 21st. Bath & Body Works’s dividend payout ratio is currently 20.83%.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on BBWI shares. The Goldman Sachs Group lowered Bath & Body Works from a “neutral” rating to a “sell” rating and cut their price target for the company from $23.00 to $19.00 in a research note on Wednesday, July 8th. Piper Sandler assumed coverage on shares of Bath & Body Works in a report on Friday, May 15th. They set a “neutral” rating and a $20.00 target price on the stock. Morgan Stanley cut their target price on shares of Bath & Body Works from $22.00 to $20.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 27th. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Finally, Deutsche Bank Aktiengesellschaft set a $22.00 price target on shares of Bath & Body Works in a research report on Thursday, August 27th. Four analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Bath & Body Works has an average rating of “Hold” and an average price target of $22.29.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.